UniProt ID | CTCFL_HUMAN | |
---|---|---|
UniProt AC | Q8NI51 | |
Protein Name | Transcriptional repressor CTCFL | |
Gene Name | CTCFL | |
Organism | Homo sapiens (Human). | |
Sequence Length | 663 | |
Subcellular Localization | Cytoplasm. Nucleus. | |
Protein Description | Testis-specific DNA binding protein responsible for insulator function, nuclear architecture and transcriptional control, which probably acts by recruiting epigenetic chromatin modifiers. Plays a key role in gene imprinting in male germline, by participating in the establishment of differential methylation at the IGF2/H19 imprinted control region (ICR). Directly binds the unmethylated H19 ICR and recruits the PRMT7 methyltransferase, leading to methylate histone H4 'Arg-3' to form H4R3sme2. This probably leads to recruit de novo DNA methyltransferases at these sites (By similarity). Seems to act as tumor suppressor. In association with DNMT1 and DNMT3B, involved in activation of BAG1 gene expression by binding to its promoter. Required for dimethylation of H3 lysine 4 (H3K4me2) of MYC and BRCA1 promoters.. | |
Protein Sequence | MAATEISVLSEQFTKIKELELMPEKGLKEEEKDGVCREKDHRSPSELEAERTSGAFQDSVLEEEVELVLAPSEESEKYILTLQTVHFTSEAVELQDMSLLSIQQQEGVQVVVQQPGPGLLWLEEGPRQSLQQCVAISIQQELYSPQEMEVLQFHALEENVMVASEDSKLAVSLAETTGLIKLEEEQEKNQLLAERTKEQLFFVETMSGDERSDEIVLTVSNSNVEEQEDQPTAGQADAEKAKSTKNQRKTKGAKGTFHCDVCMFTSSRMSSFNRHMKTHTSEKPHLCHLCLKTFRTVTLLRNHVNTHTGTRPYKCNDCNMAFVTSGELVRHRRYKHTHEKPFKCSMCKYASVEASKLKRHVRSHTGERPFQCCQCSYASRDTYKLKRHMRTHSGEKPYECHICHTRFTQSGTMKIHILQKHGENVPKYQCPHCATIIARKSDLRVHMRNLHAYSAAELKCRYCSAVFHERYALIQHQKTHKNEKRFKCKHCSYACKQERHMTAHIRTHTGEKPFTCLSCNKCFRQKQLLNAHFRKYHDANFIPTVYKCSKCGKGFSRWINLHRHSEKCGSGEAKSAASGKGRRTRKRKQTILKEATKGQKEAAKGWKEAANGDEAAAEEASTTKGEQFPGEMFPVACRETTARVKEEVDEGVTCEMLLNTMDK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Phosphorylation | ----MAATEISVLSE ----CCHHHHHHHHH | 25.06 | 24043423 | |
7 | Phosphorylation | -MAATEISVLSEQFT -CCHHHHHHHHHHHH | 15.69 | 24043423 | |
10 | Phosphorylation | ATEISVLSEQFTKIK HHHHHHHHHHHHHHH | 27.48 | 24043423 | |
14 | Phosphorylation | SVLSEQFTKIKELEL HHHHHHHHHHHHHHC | 31.39 | 24043423 | |
43 | Phosphorylation | CREKDHRSPSELEAE CCCCCCCCHHHHHHH | 29.38 | 24719451 | |
52 | Phosphorylation | SELEAERTSGAFQDS HHHHHHHHCCCCCCC | 24.02 | - | |
53 | Phosphorylation | ELEAERTSGAFQDSV HHHHHHHCCCCCCCH | 34.05 | - | |
129 | Phosphorylation | LEEGPRQSLQQCVAI ECCCCCCCHHHHHHH | 29.44 | 24043423 | |
137 | Phosphorylation | LQQCVAISIQQELYS HHHHHHHHHHCCCCC | 12.47 | 24043423 | |
143 | Phosphorylation | ISIQQELYSPQEMEV HHHHCCCCCHHHHHH | 19.97 | 24043423 | |
144 | Phosphorylation | SIQQELYSPQEMEVL HHHCCCCCHHHHHHH | 32.50 | 24043423 | |
164 | Phosphorylation | EENVMVASEDSKLAV CCCEEEECCCCHHHH | 30.44 | 24043423 | |
167 | Phosphorylation | VMVASEDSKLAVSLA EEEECCCCHHHHHHH | 26.05 | 24043423 | |
256 | Phosphorylation | KTKGAKGTFHCDVCM CCCCCCCEEECCEEE | 14.97 | - | |
265 | Phosphorylation | HCDVCMFTSSRMSSF ECCEEEEECCCHHHH | 10.02 | 29083192 | |
266 | Phosphorylation | CDVCMFTSSRMSSFN CCEEEEECCCHHHHH | 12.51 | 29083192 | |
267 | Phosphorylation | DVCMFTSSRMSSFNR CEEEEECCCHHHHHH | 29.01 | 29083192 | |
270 | Phosphorylation | MFTSSRMSSFNRHMK EEECCCHHHHHHHHC | 30.57 | 29083192 | |
271 | Phosphorylation | FTSSRMSSFNRHMKT EECCCHHHHHHHHCC | 19.73 | 29083192 | |
334 | Phosphorylation | ELVRHRRYKHTHEKP HHHHCCCCCCCCCCC | 13.69 | 28152594 | |
337 | Phosphorylation | RHRRYKHTHEKPFKC HCCCCCCCCCCCCCC | 27.81 | 28152594 | |
345 | Phosphorylation | HEKPFKCSMCKYASV CCCCCCCCCCCCEEH | 28.01 | 29083192 | |
349 | Phosphorylation | FKCSMCKYASVEASK CCCCCCCCEEHHHHH | 10.12 | 29083192 | |
351 | Phosphorylation | CSMCKYASVEASKLK CCCCCCEEHHHHHHH | 19.87 | 29083192 | |
391 | Phosphorylation | KLKRHMRTHSGEKPY HHHHHHHCCCCCCCE | 16.90 | 22210691 | |
393 | Phosphorylation | KRHMRTHSGEKPYEC HHHHHCCCCCCCEEE | 48.29 | 28985074 | |
410 | Phosphorylation | CHTRFTQSGTMKIHI ECCEECCCCCEEEEE | 32.92 | 25627689 | |
411 (in isoform 5) | Phosphorylation | - | 21.73 | 22210691 | |
412 | Phosphorylation | TRFTQSGTMKIHILQ CEECCCCCEEEEEEH | 22.12 | 27732954 | |
412 (in isoform 5) | Phosphorylation | - | 22.12 | 22210691 | |
464 | Phosphorylation | ELKCRYCSAVFHERY HHHHHHHHHHHHHHH | 20.66 | 24719451 | |
471 | Phosphorylation | SAVFHERYALIQHQK HHHHHHHHHHHHCHH | 11.63 | 28152594 | |
472 (in isoform 4) | Phosphorylation | - | 12.38 | 22210691 | |
473 (in isoform 4) | Phosphorylation | - | 2.61 | 22210691 | |
507 | Phosphorylation | HMTAHIRTHTGEKPF HEEEEEEECCCCCCE | 24.16 | - | |
509 | Phosphorylation | TAHIRTHTGEKPFTC EEEEEECCCCCCEEE | 46.56 | - | |
575 | Phosphorylation | CGSGEAKSAASGKGR CCCCCHHHHHCCCCH | 35.79 | - | |
578 | Phosphorylation | GEAKSAASGKGRRTR CCHHHHHCCCCHHHH | 40.53 | 24719451 | |
640 | Phosphorylation | FPVACRETTARVKEE CCCCCCCCCHHHHHH | 13.35 | 23532336 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CTCFL_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CTCFL_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CTCFL_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ANM7_HUMAN | PRMT7 | physical | 17048991 | |
BAG6_HUMAN | BAG6 | physical | 18765639 | |
SP1_HUMAN | SP1 | physical | 17260018 | |
SP1_HUMAN | SP1 | physical | 25363021 | |
TBP_HUMAN | TBP | physical | 25363021 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...